Floatz logo

qh101

Brain Metastasis

Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Brain Metastasis cohort.

Asset / SponsorPhaseRating
Patupilone
Novartis Pharmaceuticals
Phase 2B
Shr-A1921
Fudan University
Phase 2CCC
CABAZITAXEL
Jules Bordet Institute
Phase 2CCC
Sacituzumab Tirumotecan
Zhejiang Cancer Hospital
Phase 2CCC
Utidelone
Tianjin Medical University Cancer Institute and Hospital
Phase 2CCC
qh101 cell
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1C
Autologous Nk Cells
Peking University Third Hospital
N/AD

Same molecule, other indications

qh101 is also rated in:

cancerDormant
CC
Indicative ·
45 / 100
View asset →
metastatic malignant neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
myelodysplastic syndromeDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →